Appeal 2007-0860 Application 10/148,535 been expected to be similarly useful as the racemic mixture. As stated above, the Examiner cited prior art teaches methylphenidate (Ritalin) as a racemic mixture, placing the skilled artisan in possession of both optical isomers (i.e., 1- and d-threo-methylphenidate). Absent some difference in kind between the various isomers the skilled artisan would have seen each isomer as prima facie obvious (see In re Adamson and Duffin, 125 USPQ 233 (CCPA 1960)[)]. The skilled artisan would have expected optical isomers to be separable and isomers so separated to exhibit physiological effects at varying levels. Possessing a compound known to contain chiral centers, places all the resultant compounds in the skilled artisan's possession. It would follow therefore that the instant claims recite prima facie obvious subject matter and are properly rejected under 35 USC 103. As admitted on the record, threo- methylphenidate is taught by the Examiner cited prior art as optically active. Thus, use of one or another optical isomer by the skilled artisan would have seen as prima facie obvious, absent some difference in kind between the various isomers. see In re Adamson and Duffin, 125 USPQ 233 (CCPA 1960). (Id. at 7-8.) Appellants reiterate their arguments as to Harris, and argue that Carlson does not remedy the shortcoming of Harris (Br. 8). With respect to Carlson, Appellants argue that “although Carlson [ ] disclose[s] studies in which children diagnosed with multiple disorders, including bipolar disorder, are given a racemic mixture of methylphenidate (as well as lithium), there is no teaching whatsoever by Carlson [ ] regarding the use of [l-threo-methylphenidate] to treat bipolar disorder.” (Id.) We agree that the Examiner has failed to set forth a prima facie case of obviousness, and the rejection is reversed. Carlson is drawn to looking at children that exhibit symptoms of both ADHD and bipolar disorder (id. at 262). Carlson’s study asks the question 8Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
Last modified: September 9, 2013